This invention pertains to compounds which specifically inhibit the adenosine A.sub.1 receptor and the use of these compounds to treat a disease associated with A.sub.1 adenosine receptors in a subject.

Deze uitvinding behoort tot samenstellingen die specifiek de adenosine A.sub.1 receptor en het gebruik van deze samenstellingen remmen om een ziekte te behandelen verbonden aan adenosine A.sub.1 receptoren bij een onderwerp.
 
Web www.patentalert.com

< Cholesterol and triglyceride-modulating drugs and methods

< Concurrent flow mixing methods and apparatuses for the preparation of gene therapy vectors and compositions prepared thereby

> Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders

> Processes for making surfactants via absorptive separation and products thereof
~ 00097